T2D, no complication |
0.785 ± 0.11 |
[43] |
Angina disutility, year of event |
–0.09 ± 0.01 |
[41] |
Congestive heart failure disutility, year of event |
–0.108 ± 0.01 |
[41] |
Myocardial infarction disutility, year of event |
–0.055 ± 0.01 |
[41] |
Stroke disutility, year of event |
–0.164 ± 0.01 |
[41] |
Peripheral vascular disease disutility, year of event |
–0.061 ± 0.01 |
[41] |
Gross proteinuria disutility, year of event |
–0.048 ± 0.01 |
[41] |
Hemodialysis disutility, year of event |
–0.164 ± 0.03 |
[41] |
Peritoneal dialysis disutility, year of event |
–0.204 ± 0.03 |
[41] |
Kidney transplant disutility, year of event |
–0.023 ± 0.12 |
[41] |
Background diabetic retinopathy disutility, year of event |
–0.04 ± 0.02 |
[41] |
Proliferative diabetic retinopathy disutility, year of event |
–0.07 ± 0.02 |
[41] |
Cataract disutility, year of event |
–0.016 ± 0.02 |
[41] |
Macular edema disutility, year of event |
–0.04 ± 0.02 |
[41] |
Severe vision loss/blindness disutility, year of event |
–0.074 ± 0.01 |
[41] |
Neuropathy disutility, year of event |
–0.084 ± 0.01 |
[41] |
Active foot ulcer disutility, year of event |
–0.17 ± 0.01 |
[41] |
Amputation disutility, year of event |
–0.28 ± 0.01 |
[41] |
Diurnal severe hypoglycemia event (SHE1 and SHE2) requiring any third party medical assistance |
–0.047 ± 0.014 |
[42] |
Nocturnal severe hypoglycemia event (SHE1 and SHE2) requiring any third party medical assistance |
–0.051 ± 0.014 |
[42] |